Published in J Lab Clin Med on March 01, 2002
Oxidized low-density lipoprotein. Methods Mol Biol (2010) 1.10
Biomarkers of exposure to vitamins A, C, and E and their relation to lipid and protein oxidation markers. Eur J Nutr (2008) 0.88
Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med (2007) 18.78
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med (2006) 6.14
Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension (2013) 5.88
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
The effects of tibolone in older postmenopausal women. N Engl J Med (2008) 3.96
Evidence-based guidelines for cardiovascular disease prevention in women. Circulation (2004) 3.39
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol (2006) 2.57
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol (2010) 2.55
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation (2009) 2.41
Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study. JAMA Intern Med (2013) 2.36
Nine-year trends and racial and ethnic disparities in women's awareness of heart disease and stroke: an American Heart Association national study. J Womens Health (Larchmt) (2007) 2.08
American Heart Association and American Stroke Association national survey of stroke risk awareness among women. Circulation (2005) 1.95
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2002) 1.72
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69
Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project. Stroke (2003) 1.61
Evidence-based guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol (2004) 1.59
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk. J Natl Cancer Inst (2008) 1.56
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial. Circ Cardiovasc Qual Outcomes (2013) 1.55
Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation (2013) 1.52
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol (2004) 1.49
Controversy and consensus about statin use: it is not about the sex. J Am Coll Cardiol (2012) 1.45
Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation (2013) 1.35
Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr (2012) 1.33
A negative carotid plaque area test is superior to other noninvasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler Thromb Vasc Biol (2005) 1.29
Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis (2004) 1.27
Quality of cardiovascular disease preventive care and physician/practice characteristics. J Gen Intern Med (2006) 1.19
Influence of caregiving on lifestyle and psychosocial risk factors among family members of patients hospitalized with cardiovascular disease. J Gen Intern Med (2008) 1.18
Ischemic preconditioning: nearly two decades of research. A comprehensive review. Atherosclerosis (2004) 1.15
Clinical utility of a fingerstick technology to identify individuals with abnormal blood lipids and high-sensitivity C-reactive protein levels. Am J Health Promot (2009) 1.07
Cholesterol predicts stroke mortality in the Women's Pooling Project. Stroke (2002) 1.04
Association of acculturation status with beliefs, barriers, and perceptions related to cardiovascular disease prevention among racial and ethnic minorities. J Transcult Nurs (2009) 1.03
Patient-related diet and exercise counseling: do providers' own lifestyle habits matter? Prev Cardiol (2010) 1.03
Gender disparities in the quality of cardiovascular disease care in private managed care plans. Womens Health Issues (2007) 1.02
Risk Factors in first presentation acute coronary syndromes (ACS): how do we move from population to individualized risk prediction? Angiology (2009) 1.02
Prevalence of breast arterial calcifications in an ethnically diverse population of women. Ann Epidemiol (2005) 1.01
The gender gap in coronary heart disease mortality: is there a difference between blacks and whites? J Womens Health (Larchmt) (2005) 1.01
Cardiovascular risk factors in ethnic minority women aged < or =30 years. Am J Cardiol (2002) 1.00
Contemporary awareness and understanding of cholesterol as a risk factor: results of an American Heart Association national survey. Arch Intern Med (2003) 1.00
Limitations of current cardiovascular disease risk assessment strategies in women. J Womens Health (Larchmt) (2006) 1.00
C-reactive protein--to screen or not to screen? N Engl J Med (2002) 1.00
Knowledge, preventive action, and barriers to cardiovascular disease prevention by race and ethnicity in women: an American Heart Association national survey. J Womens Health (Larchmt) (2010) 0.99
The prognostic role of the ECG in primary pulmonary hypertension. Chest (2002) 0.98
Lifestyle and psychosocial risk factors predict non-adherence to medication. Ann Behav Med (2010) 0.98
Relationship between arterial stiffness and subclinical aortic atherosclerosis. Circulation (2004) 0.98
Secondary causes of dyslipidemia. Am J Cardiol (2012) 0.98
The association between educational level and risk of cardiovascular disease fatality among women with cardiovascular disease. Womens Health Issues (2005) 0.97
Reduced bone mineral density is associated with breast arterial calcification. J Clin Endocrinol Metab (2007) 0.97
Psychosocial aspects of pulmonary hypertension: a review. Psychosomatics (2007) 0.97
Validation of the MEDFICTS dietary assessment questionnaire in a diverse population. J Am Diet Assoc (2008) 0.97
Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial. Am J Cardiol (2002) 0.96
Healing the heart: a randomized pilot study of a spiritual retreat for depression in acute coronary syndrome patients. Explore (NY) (2011) 0.96
Physical activity as a potential mechanism through which social support may reduce cardiovascular disease risk. J Cardiovasc Nurs (2008) 0.95
Ethnic differences in barriers and referral to cardiac rehabilitation among women hospitalized with coronary heart disease. Prev Cardiol (2006) 0.94
Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial. J Bone Miner Res (2008) 0.93
Cardiovascular disease knowledge, medication adherence, and barriers to preventive action in a minority population. Prev Cardiol (2007) 0.93
The effect of St John's Wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity. J Cardiovasc Pharmacol (2011) 0.93
The effect of patient choice of intervention on health outcomes. Contemp Clin Trials (2008) 0.93
The impact of time and day on the presentation of acute coronary syndromes. Clin Cardiol (2006) 0.92
Low social support level is associated with non-adherence to diet at 1 year in the Family Intervention Trial for Heart Health (FIT Heart). J Nutr Educ Behav (2010) 0.91
Spotlight on gender. Cardiovasc Res (2002) 0.91
Racial/ethnic and age differences in women's awareness of heart disease. J Womens Health (Larchmt) (2012) 0.88
The relation of blood pressure to coronary heart mortality in different age groups varies by ethnicity. Am J Hypertens (2006) 0.88
Aspirin chemoprevention: one size does not fit all. Circulation (2008) 0.87
Raloxifene and risk for stroke based on the framingham stroke risk score. Am J Med (2009) 0.87
National women's knowledge of stroke warning signs, overall and by race/ethnic group. Stroke (2014) 0.87
Caregiver status: a simple marker to identify cardiac surgery patients at risk for longer postoperative length of stay, rehospitalization, or death. J Cardiovasc Nurs (2013) 0.86
Predictors of quality of life among women with coronary heart disease. Qual Life Res (2006) 0.85
Behavioral medicine: the challenge of integrating psychological and behavioral approaches into primary care. Eff Clin Pract (2002) 0.85
Altered cutaneous microvascular responses to reactive hyperaemia in coronary artery disease: a comparative study with conduit vessel responses. Clin Sci (Lond) (2002) 0.85
Effect of statin use in patients with acute coronary syndromes and a serum low-density lipoprotein<or=80 mg/dl. Am J Cardiol (2005) 0.85
Physician variation in perceived barriers to personal health. Int J Gen Med (2012) 0.85
Survival in systemic sclerosis with pulmonary arterial hypertension has not improved in the modern era. Chest (2013) 0.85
Effect of an intervention to improve the cardiovascular health of family members of patients with coronary artery disease: a randomized trial. CMAJ (2013) 0.84
Comparison of the relation of triglyceride-rich lipoproteins and muscular artery compliance in healthy women versus healthy men. Am J Cardiol (2005) 0.84
Medication adherence is associated with having a caregiver among cardiac patients. Ann Behav Med (2013) 0.84
The ezetimibe controversy: implications for clinical practice. Ther Adv Cardiovasc Dis (2011) 0.83
Weight changes and obesity predict impaired resting and endothelium-dependent myocardial blood flow in postmenopausal women. Clin Cardiol (2005) 0.82
Patient awareness of the risks for heart disease posed by air pollution. Prog Cardiovasc Dis (2011) 0.82
Air Pollution Exposure and Blood Pressure: An Updated Review of the Literature. Curr Pharm Des (2015) 0.82
Task Force on Strategic Research Direction: Population/Outcomes/Epidemiology/Social Science Subgroup key science topics report. Circulation (2002) 0.82
Predictors and barriers to timely medical follow-up after cardiovascular disease risk factor screening according to race/ethnicity. J Natl Med Assoc (2008) 0.81
Does stage of change modify the effectiveness of an educational intervention to improve diet among family members of hospitalized cardiovascular disease patients? J Am Diet Assoc (2010) 0.81
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women. Arterioscler Thromb Vasc Biol (2004) 0.81
Usefulness of an acute coronary syndrome pathway to improve adherence to secondary prevention guidelines. Am J Cardiol (2003) 0.81
Cardiovascular response to exercise in elite ice hockey players. Can J Cardiol (2004) 0.80
Effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention. Am J Cardiol (2004) 0.80
Lifestyle changes in New Yorkers after September 11, 2001 (data from the Post-Disaster Heart Attack Prevention Program). Am J Cardiol (2002) 0.80
Predictors of physical activity at 1 year in a randomized controlled trial of family members of patients with cardiovascular disease. J Cardiovasc Nurs (2010) 0.79
Self-reported physical activity and myocardial flow reserve in postmenopausal women at risk for cardiovascular disease. J Womens Health (Larchmt) (2006) 0.79
The interpretation of the electrocardiogram in patients with pulmonary hypertension: the need for clinical correlation. Ital Heart J (2003) 0.79
Effect of gender, caregiver, on cholesterol control and statin use for secondary prevention among hospitalized patients with coronary heart disease. Am J Cardiol (2012) 0.79
Usefulness of self-reported periodontal disease to identify individuals with elevated inflammatory markers at risk of cardiovascular disease. Am J Cardiol (2008) 0.79
Heart disease management by women: does intervention format matter? Health Educ Behav (2007) 0.78
Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular disease. Am Heart J (2013) 0.78